|
Market Closed -
London S.E.
11:35:23 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.1200 GBX | +2.13% |
|
-4.00% | -44.19% |
| 08-27 | JPM Global Core liquidation; IGC shareholder's rebuke | AN |
| 08-27 | Oxford Biodynamics plc Announces Appointment of Richard Compton as Executive Director, Effective August 27, 2026 | CI |
| Market Cap | 6.02M 6.99M 5.65M 5.16M 9.69M 665M 9.76M 66.94M 26.04M 337M 26.24M 25.67M 1.12B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 10.92M 12.68M 10.25M 9.36M 17.58M 1.21B 17.71M 121M 47.27M 612M 47.62M 46.58M 2.03B | EV / Sales 2026 * |
5.83x | EV / Sales 2027 * | - |
| Free-Float |
94.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.13% | ||
| 1 week | -4.00% | ||
| Current month | +9.09% | ||
| 1 month | +4.35% | ||
| 3 months | -35.14% | ||
| 6 months | -52.00% | ||
| Current year | -44.19% |
| 1 week | 0.11 |  | 0.13 |
| 1 month | 0.1 | | 0.15 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 53.6 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Compton
CEO | Chief Executive Officer | - | 2026-06-29 |
| Chief Tech/Sci/R&D Officer | 64 | 2007-06-07 | |
Paul Stockdale
DFI | Director of Finance/CFO | - | 2017-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2007-06-07 | |
Paul Stockdale
BRD | Director/Board Member | - | 2017-09-14 |
David Holbrook
BRD | Director/Board Member | 65 | 2019-04-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/10/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 11/10/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 11/10/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.13% | -4.00% | -74.74% | -98.92% | 6.98M | |
| -1.56% | -1.98% | -21.29% | -31.48% | 2.52B | |
| +0.81% | +16.00% | +15.80% | -82.62% | 2.2B | |
| -0.63% | -1.34% | -16.17% | -9.83% | 352M | |
| +0.66% | +4.32% | -44.43% | - | 52.91M | |
| Average | +0.28% | +2.49% | -28.17% | -55.71% | 1.03B | |
| Weighted average by Cap. | -0.45% | +6.41% | -5.33% | -52.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87M 2.17M 1.76M 1.6M 3.01M 207M 3.04M 20.83M 8.1M 105M 8.16M 7.99M 347M | - |
| Net income | - | - |
| Net Debt | 4.9M 5.69M 4.6M 4.2M 7.89M 542M 7.95M 54.55M 21.23M 275M 21.38M 20.92M 910M | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | GBX 0.1200 | +2.56% | 21,540,567 |
| 26-08-27 | GBX 0.1170 | -.--% | 11,495,458 |
| 26-08-26 | GBX 0.1170 | -4.10% | 159,729,348 |
| 26-08-25 | GBX 0.1220 | -6.15% | 938,302 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001200GBP
Average target price
0.0100GBP
Spread / Average Target
+733.33%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Select your edition
All financial news and data tailored to specific country editions
